Cleared Traditional

K160967 - Finapres Nova Noninvasive Hemodynamic Monitor

K160967 is an FDA 510(k) clearance for Finapres Nova Noninvasive Hemodynamic M..., manufactured by Finapres Medical Systems B.V.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 377-day FDA review.

K160967 · Finapres Medical Systems B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
377d
Days
Class 2
Risk

K160967 is an FDA 510(k) clearance for the Finapres Nova Noninvasive Hemodynamic Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Finapres Medical Systems B.V. (Amsterdam, NL). The FDA issued a Cleared decision on April 18, 2017 after a review of 377 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Finapres Medical Systems B.V. devices

FDA 510(k) Submission Details - K160967

510(k) Number K160967 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2016
Decision Date April 18, 2017
Days to Decision 377 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
252d slower than avg
Panel avg: 125d · This submission: 377d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K160967.
A&D Medical UA-1200BLE UltraConnect Digital Blood Pressure Monitor
K163683 · A&D Company, Ltd. · May 2017
CareTaker Continuous Non-lnvasive Blood Pressure Monitor, CareTaker Wireless Vital Signs Monitor, CareTaker Physiological Monitor
K163255 · Caretaker Medical, LLC · Apr 2017
HEM-9210T
K163235 · Omron Healthcare, Inc. · Apr 2017
Arm automatic blood pressure monitor
K161712 · Shenzhen Pump Medical System Co., Ltd. · Apr 2017
Bluetooth blood pressure monitor
K161530 · Shenzhen Kingyield Technology Co., Ltd. · Mar 2017
Consult Station TS
K153600 · H4D Sas · Mar 2017